Lead Counsel for the Indirect Purchaser Plaintiffs today announced that settlements have been reached with nearly all the remaining defendants in a longstanding antitrust litigation currently pending in federal court in the Northern District of California, as well as in state courts throughout the United States. The total of all settlements reached in this case so far is over $285 million. This is one of the largest settlements ever of an indirect purchaser antitrust case in the United States.
On August 25, 2009, Solvay Pharmaceuticals, Inc. entered into a Settlement Agreement with Plaintiffs in Yarrington v. Solvay Pharmaceuticals, Inc., which alleges that Defendant Solvay Pharmaceuticals, Inc. (“Solvay”) violated state unfair competition and false and deceptive advertising laws in marketing Estratest and Estratest H.S., prescription hormone therapy drugs.
